FR2925067B1 - Vecteurs vaccinaux derives de leporipoxvirus - Google Patents

Vecteurs vaccinaux derives de leporipoxvirus

Info

Publication number
FR2925067B1
FR2925067B1 FR0708826A FR0708826A FR2925067B1 FR 2925067 B1 FR2925067 B1 FR 2925067B1 FR 0708826 A FR0708826 A FR 0708826A FR 0708826 A FR0708826 A FR 0708826A FR 2925067 B1 FR2925067 B1 FR 2925067B1
Authority
FR
France
Prior art keywords
leporipoxvirus
vectors derived
vaccine vectors
vaccine
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0708826A
Other languages
English (en)
Other versions
FR2925067A1 (fr
Inventor
Stephane Bertagnoli
Beatrice Pignolet
Jacqueline Gelfi
Bouclainville Christelle Camus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
ECOLE Nationale Veterinaire Toulouse
Original Assignee
Institut National de la Recherche Agronomique INRA
ECOLE Nationale Veterinaire Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA, ECOLE Nationale Veterinaire Toulouse filed Critical Institut National de la Recherche Agronomique INRA
Priority to FR0708826A priority Critical patent/FR2925067B1/fr
Priority to PCT/FR2008/001678 priority patent/WO2009098410A1/fr
Priority to US12/808,971 priority patent/US20110052626A1/en
Priority to EP08872097A priority patent/EP2235166A1/fr
Priority to CA2709925A priority patent/CA2709925A1/fr
Publication of FR2925067A1 publication Critical patent/FR2925067A1/fr
Application granted granted Critical
Publication of FR2925067B1 publication Critical patent/FR2925067B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24061—Methods of inactivation or attenuation
    • C12N2710/24062—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0708826A 2007-12-18 2007-12-18 Vecteurs vaccinaux derives de leporipoxvirus Expired - Fee Related FR2925067B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0708826A FR2925067B1 (fr) 2007-12-18 2007-12-18 Vecteurs vaccinaux derives de leporipoxvirus
PCT/FR2008/001678 WO2009098410A1 (fr) 2007-12-18 2008-12-03 Vecteurs vaccinaux derives de leporipoxvirus
US12/808,971 US20110052626A1 (en) 2007-12-18 2008-12-03 Leporipoxvirus-derived vaccine vectors
EP08872097A EP2235166A1 (fr) 2007-12-18 2008-12-03 Vecteurs vaccinaux derives de leporipoxvirus
CA2709925A CA2709925A1 (fr) 2007-12-18 2008-12-03 Vecteurs vaccinaux derives de leporipoxvirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0708826A FR2925067B1 (fr) 2007-12-18 2007-12-18 Vecteurs vaccinaux derives de leporipoxvirus

Publications (2)

Publication Number Publication Date
FR2925067A1 FR2925067A1 (fr) 2009-06-19
FR2925067B1 true FR2925067B1 (fr) 2010-01-15

Family

ID=39185848

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0708826A Expired - Fee Related FR2925067B1 (fr) 2007-12-18 2007-12-18 Vecteurs vaccinaux derives de leporipoxvirus

Country Status (5)

Country Link
US (1) US20110052626A1 (fr)
EP (1) EP2235166A1 (fr)
CA (1) CA2709925A1 (fr)
FR (1) FR2925067B1 (fr)
WO (1) WO2009098410A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2341356C (fr) * 2000-04-14 2011-10-11 Transgene S.A. Poxvirus specifique d'une infection ciblee
CA2439872C (fr) * 2001-03-08 2009-12-15 Akzo Nobel Nv Vaccins vectoriels a base de leporipox

Also Published As

Publication number Publication date
FR2925067A1 (fr) 2009-06-19
WO2009098410A1 (fr) 2009-08-13
CA2709925A1 (fr) 2009-08-13
EP2235166A1 (fr) 2010-10-06
US20110052626A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
DK2114993T3 (da) Vaccine
DK2376107T3 (da) Immunstimulerende oligonukleotider
BRPI0911604A2 (pt) vacinas de polipeptídeo de flagelina
BRPI1010210A2 (pt) membro de fixação arqueado
IL219048A (en) Peptide compounds derived from urcl10
ATE450271T1 (de) Impfstoff
NO20091125L (no) Stigerorsklemme
FR2941143B1 (fr) Agrafe chirurgicale auto-agrippante
BRPI0917205A2 (pt) vacina polivalente
UY33125A (es) Diaza-espiro-[5,5]-undecanos
BRPI0813144A2 (pt) Couro
DE602009000580D1 (de) Endoskopsystem
DK2307844T3 (da) Indspændingssystem
DK2048424T3 (da) Klemme
BRPI0814763A2 (pt) Peptídeos imunomoduladores
DK2307543T3 (da) Forbedret proteinekspressionssystem
BR112012006603A2 (pt) braçadeira de fixação
DK2346756T3 (da) Cleaning-in-place system
BRPI0921578A2 (pt) vacinas unitemporais
BRPI0820750A2 (pt) Proteína cíclica isenta de cisteínas
BRPI0907961A2 (pt) Arranjo de aperto
NO20071696L (no) Klemme
DK2175881T3 (da) Intradermal influenzavaccine
BRPI0921161A2 (pt) teteira
BRPI0917522A2 (pt) Protetores de cultura

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130830